Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
Advances in Biochemical Psychopharmacology|January 1, 1980
Gamma-Acetylenic GABA in tardive dyskinesiaD E Casey, J Gerlach, G Magelund, et al.Psychopharmacology|January 1, 1984
Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonismU Noring, U J Povlsen, D E Casey, et al.Archives of Internal Medicine|June 28, 1993
The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disordersL Ganzini, D E Casey, W F Hoffman, et al.Biological Psychiatry|November 1, 1991
Three-year follow-up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratioW F Hoffman, L Ballard, E H Turner, et al.Archives of General Psychiatry|March 1, 1991
The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled studyL Ganzini, R T Heintz, W F Hoffman, et al.Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1989
Lack of platelet monoamine oxidase activity in Cebus monkeys (Cebus albifrons)R Heintz, M A Richardson, A S Perumal, et al.Archives of General Psychiatry|February 1, 1981
Effect of des-tyrosine-gamma-endorphin in tardive dyskinesiaD E Casey, S Korsgaard, J Gerlach, et al.Psychopharmacology Bulletin|January 1, 1992
Tardive dyskinesia and diabetes mellitusL Ganzini, D E Casey, W F Hoffman, et al.General Hospital Psychiatry|September 1, 1992
Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residentsT E Hansen, W L Brown, R M Weigel, et al.Psychopharmacology|October 18, 2001
The behavioral effects of acute and chronic JL 13, a putative antipsychotic, in Cebus non-human primatesD E Casey, J Bruhwyler, J Delarge, et al.Pageof 12